BID

Bide Pharmatech is a high-tech enterprise focused on the upstream segment of the pharmaceutical research and development value chain. Headquartered in Shanghai, the company specializes in the R&D, design, production, and sales of drug molecular building blocks and scientific reagents. With a catalog of over 400,000 products, Bide Pharmatech provides innovative-structure and multi-functional chemical intermediates to global pharmaceutical companies and research institutions. The company's services support key stages of drug discovery, including target identification, lead compound optimization, and candidate discovery. Bide Pharmatech is publicly listed on the Shanghai Stock Exchange and maintains a significant global presence with operations in North America, Europe, and India.